Not the same excipients as test clinical trials

A multinational, multicenter extension study to investigate the long-term safety, tolerability and efficacy of balinatunfib in adults with Crohn’s disease or ulcerative colitis

This study looks at a new medicine called balinatunfib for adults with Crohn's disease or ulcerative colitis. It mainly checks for any side effects and how safe it is over a longer time. It also looks at if the treatment helps improve symptoms and gut health.